PRESTRELSKI STEVEN (Chief Scientific Officer) sold 2.0% of their position (10K shares) of XERIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $40.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/13/2021ACC: 0001346302-21-000031
Officer· Chief Scientific Officer
Since Dec 2018
-10K
Net shares
Net seller
$40.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10K
Price / share
$4.07
Trade value
$40.73K
% of position
2.0%
4/12/2021
506.82K→496.82K
Total
Net shares
−10K
Net value
-$40.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/12/2021 | S · Sale | −10K | $4.07 | $40.73K | 2.0% | 506.82K | 496.82K |
| Total | −10K | -$40.73K | ||||||
Derivative Transactions0
No derivative transactions reported